)
Scienture Holdings (SCNX) investor relations material
Scienture Holdings AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Virtual meeting called to order; Louis Kern served as secretary and Emily White as inspector of election.
Quorum confirmed with at least one-third of voting shares represented by webcast attendance or proxy.
Four matters scheduled for a vote: director elections, auditor ratification, advisory executive compensation, and conditional adjournment.
Proxy statement was available on the meeting webpage; stockholders could vote or change prior votes online.
Board and executive committee updates
Mayur Doshi, Donald G. Fell, Shankar Hariharan, Subbarao Jayanthi, and Narasimhan Mani were duly elected as directors by plurality vote.
Shareholder proposals
Proposal 1 sought election of five director nominees; nominees with the most votes for would be elected.
Proposal 2 sought ratification of CM3 Advisory as independent auditor for the FY ending December 31, 2026.
Proposal 3 sought non-binding advisory approval of named executive officer compensation as described in the proxy statement.
Proposal 4 sought authority to adjourn, if necessary and appropriate, to solicit proxies if votes or quorum were insufficient.
- Two new therapies launched in 2026 drive revenue growth, with a strong pipeline and expanding coverage.SCNX
H.C. Wainwright 28th Annual Global Investment Conference - Annual meeting to vote on directors, auditor, executive pay, and governance matters.SCNX
Proxy filing - Rapid revenue growth and FDA-approved launches highlight a strong specialty pharma pipeline.SCNX
Corporate presentation - 2026 meeting covers director elections, auditor ratification, and executive pay, with strong governance.SCNX
Proxy filing - Q2 2026 revenue surged 510% on ARBLI™ sales, with net loss narrowing and strong liquidity maintained.SCNX
Q2 2026 - Two FDA-approved launches and a robust pipeline drive revenue growth and near-term profitability.SCNX
WTR Insights Conference: Powered by The Small Cap Showcase - Revenue fell sharply in Q3 2024 as the company shifted focus to pharma R&D and paid large dividends.SCNX
Q3 2024 - Specialty pharma pivot with high R&D spend, ongoing losses, and up to $50M ELOC funding planned.SCNX
Registration filing - Biopharma pivots to CNS/CVS drugs, seeks $50M equity, faces losses, dilution, and regulatory risk.SCNX
Registration filing
Next Scienture Holdings earnings date
Next Scienture Holdings earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)